Molecular Diagnostics - Point of Care Molecular Diagnostics Market Indicates Impressive Growth
The global point of care molecular diagnostics market was valued at USD 632.5 Million in 2017 and is projected to reach USD 1,440.2 Million in 2023, at a CAGR of 14.7%.
(firmenpresse) - What are the Global Growth Factors?
Growth in the point of care molecular diagnostics market is mainly driven by factors such as the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests.
What The Experts Says about the Market Growth?
The global point of care molecular diagnostics market is expected to reach USD 1440.2 Million by 2023 from USD 725.5 Million in 2018, at a CAGR of 14.7%.
Browse and in-depth TOC on "Point of Care Molecular Diagnostics Market"
68 – Tables
23 – Figures
106 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127
Global Market Segmentation:
On the basis of product & service, the market is broadly segmented into assays & kits, instruments/analyzers, software & services. The assays & kits segment is expected to hold the largest share of the market in 2018 and is also projected to grow at highest CAGR in the global POC molecular diagnostics market during the forecast period.
On the basis of technology, the market is broadly segmented into RT-PCR, INAAT, and other technologies. The RT-PCR segment is expected to account for the largest share of the global POC molecular diagnostics market in 2018. RT-PCR is a highly cost-effective and preferred technology for POC settings that allows for the concurrent monitoring of expression levels of multiple genetic messages. Such benefits are driving the growth of the RT PCR segment.
On the basis application, the market is broadly segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications (meningococcal meningitis, malaria, herpes simplex virus, Ebola, Zika virus).
On the basis of end users, the market is broadly segmented into physician offices, hospital EDs and ICUs, research institutes, and other end users. The physician offices segment is expected to hold the largest share of the market.
Geographical Analysis of Point of Care Molecular Diagnostics Market:
North America is expected to account for the largest share of the global POC molecular diagnostics market. The growing prevalence of infectious diseases, increasing number of CLIA product approvals, and rising government initiatives to support the adoption of POC molecular diagnostics in this region are driving the market growth.
Get Your Queries Resolved From Subject Expert | Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=143524127
Key Market Players:
Some of the key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Biomerieux SA (France), and Danaher (US). Product development was the major strategy adopted by these major players to maintain their leadership position in the global POC molecular diagnostics market.
Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 09.10.2019 - 10:16 Uhr
Sprache: Deutsch
News-ID 1760359
Anzahl Zeichen: 3347
Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:
Northbrook
Telefon: 18886006441
Kategorie:
Medizintechnik
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 09.10.2019
Diese Pressemitteilung wurde bisher 355 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Molecular Diagnostics - Point of Care Molecular Diagnostics Market Indicates Impressive Growth"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private
Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco
Weitere Mitteilungen von MnM
Neue Herausforderungen für Pharma Großhändler durch die MDR ...
Medical Device Regulation ist in diesen Tagen das Thema auf vielen Branchenveranstaltungen der Pharmabranche. Die neuen Anforderungen müssen für die ersten Produkte bereits zum Mai 2020 umgesetzt werden, dabei müssen neben den Arbeitsprozessen auch digitale Prozesse in Unternehmen angepasst bzw.
ABW-BodyMapper 4D ...
Der ABW-BodyMapper 4D ist das erste rasterstereographische Vermessungssystem, das den gesamten Körper von Kopf bis Fuß mit 2 Mio. Bildpunkten erfasst. Im Unterschied zur konventionellen ?Wirbel-säulendiagnostik? ist nun erstmals eine ganzheitliche Haltungsdiagnostik möglich. Durch die dynamische
MEDIZINISCHE STECKVERBINDERTECHNIK von BIX und EDAC ...
Karl Kruse, der Spezialist für die internationale Lokalisierung und Beschaffung elektronischer und elektromechanischer Bauelemente, inkl. abgekündigter und knapper Teile, prüft Karl Kruse bereits vorab alle Bausteine die für ein medizinisches Gerät benötigt werden, um richtige Empfehlungen fü
Besuchen Sie SinfoMed auf dem DKOU ...
auf dem diesjährigen DKOU in Berlin sind wir wieder mit zwei interessanten ADO-Kursen vertreten. Nutzen Sie die Gelegenheit und lernen Sie die erfolgreichen SinfoMed-Konzepte für die Konservative Orthopädie kennen. Während des gesamten Kongresses präsentieren wir Ihnen diese auch gerne an un
